Opening of the Conference



Tuesday, 15. October 2013 | 10:15 Uhr

Speaker

Hans Groth

Organisation

President of the Foundation

Reporting

Dr. Hans Groth, Präsident der Stiftung Academia Engelberg, hiess die Gäste der zwölften Konferenz herzlich willkommen. „Zum ersten Mal habe ich als neuer Präsident die Ehre, die Eröffnungsansprache zu halten. Mein Vorgänger, Klaus Hug, hat dies in den vergangenen elf Jahren überaus routiniert und inhaltsreich gemacht. Ich werde und muss mich also anstrengen!“ meinte er.
Die Zukunft des Sozialstaates drehe sich um zwei Fragen: „Erstens: Wie geht die Schweiz, ein kleines, sehr wohlhabendes und neutrales Land in der Mitte Europas – vor dem Hintergrund des demografischen Wandels mit den Errungenschaften des Sozialstaates und natürlich auch den liebgewonnenen Ansprüchen um?
Und zweitens: In welchen «Handlungsfeldern» können und müssen wir aktiv werden, um die Errungenschaft „Sozialstaat“ auch im 21. Jahrhundert zu einer Chance, zu einer Opportunität und schlussendlich zu einem Wettbewerbsvorteil für uns und unser Land weiter zu entwickeln?
Damit der Sozialstaat in Zukunft bestehen kann, muss er sich an die Rahmenbedingungen des 21. Jahrhunderts anpassen. Diese sind anders, als im 19. Jahrhundert, als der Sozialstaat seinen Ursprung fand. Unternehmen wir nichts, oder ruhen wir uns aus, dann wird Wohlfahrt und Wohlstand in diesem Land nicht mehr zukunftsfähig sein!“ warnte Hans Groth.

Eröffnungsansprache von Dr. Hans Groth Präsident der Stiftung Academia Engelberg

Hans Groth

Hans Groth holds the office of President of the Foundation Board of Academia Engelberg.

Dr. med. Hans Groth, MBA is Senior Director of Healthcare Policy & Market Access for the Oncology Business Unit from Pfizer Europe and Member of the Executive Board for Pfizer Switzerland. His responsibilities include governmental affairs, healthcare policy, pricing & reimbursement across Europe and tailored communication strategies to gain broad societal acceptance of innovative medicines and modern personalized oncology treatment regimen in particular. Hans Groth has been working with Pfizer for twenty-three years. He has comprehensive experience in over 30 healthcare markets including Western Europe, Eastern Europe, the USA and Canada.

His previous responsibilities have included medical affairs, clinical research, regulatory, marketing & sales as well as international public affairs including negotiating pricing and access conditions with government authorities as well as healthcare payers. In 2003, he was appointed “Pfizer Global Health Fellow” by UNAIDS to conduct case studies in Central Asia and Siberia in order to quantify the threat potential of HIV/AIDS/TB in that region. For his subsequent commitment towards supporting public health infrastructure projects in Southeast Siberia and Kirgizstan, he received in 2008 the “Pfizer Global Health Fellow Award”.

For the past ten years, Dr. Groth has been studying the interaction between global demographic change, economic development, wealth and societal stability (c.f. “Europe’s Demographic Challenge – Unlocking the Value of Health” Hans Groth & Dr. Nicholas Eberstadt, 2007). The focus of his research has built upon theories of economic development & productivity and employing the value of health as a sustainable tool to unlock new ways to tackle the imminent challenges of demographic change. Since 2009, Dr. Groth has worked as a guest lecturer at the University of St. Gallen/Switzerland with the topic “Megatrend: Global Demographic Change”. He is also Chairman of the Board of the Demographic & Ageing Forum (WDA) at the University of St. Gallen and elected member of the “Global Agenda Council on Global Population Growth” for the World Economic Forum (WEF).

Dr. Groth is married with two adult children. He has dual citizenship of Switzerland and Germany.

Donators and Partners

The ETH Board is responsible for the strategic leadership of the ETH domain and assumes the supervision of its institutions. Its close relationship with the ETH Council has contributed to the successful continuation of Academia Engelberg Foundation since 2000.

The Foundation promotes research into the connecting human fundamentals of science. Academia Engelberg Foundation and the Foundation for Basic Research in Human Sciences have entered into a cooperation agreement for the period 2011 to 2015.

Helvetia is a quality-oriented comprehensive insurance company with over 150 years of experience. Academia Engelberg Foundation is convinced it will be able to use important synergies from the partnership starting in 2015.

DIE HIRSCHMANN STIFTUNG ist eine gemeinnützige schweizerische Stiftung. 1985 wurde sie vom Unternehmer und Aviatik-Pionier Carl W. Hirschmann gegründet.

A partnership with the University of Lucerne has existed since summer 2013. Since 2016 we have also a parthership with the Faculty of Economics and Management of the University of Lucerne. Through these partnerships, synergies are used and joint projects are tested and realized. The University of Lucerne currently consists of three faculties: the faculties for Theology, Culture and Social Sciences, and Law.

The focus of the Foundation is the promotion of organizations in the areas of culture and arts, architecture, design, music, sports, education, and science. It has been a partner of Academia Engelberg Foundation since 2014.